Abstract
Community-acquired pneumonia (CAP) is a relatively common and potentially serious infection that affects both immunocompetent and immunosuppressive adults throughout the world. The annual incidence of CAP in the United States is approximately 4 million cases. CAP due to atypical pathogens accounts for approximately 20 to 40 percent of cases necessitating hospitalization. There are few data regards to the prevalence rates of severe CAP due to atypical pathogens necessitating admission to the intensive care unit. This review article summarizes clinical features, diagnostic criteria, differential diagnosis, and management based on guidelines of medical societies.
Keywords: Community-acquired pneumonia, atypical pathogens, legionella, mycoplasma, chlamydia, intensive care unit
Current Respiratory Medicine Reviews
Title: Severe Community-Acquired Pneumonia (CAP) due to Atypical Pathogens
Volume: 1 Issue: 3
Author(s): Argyris Michalopoulos, Michael Rizos and Matthew E. Falagas
Affiliation:
Keywords: Community-acquired pneumonia, atypical pathogens, legionella, mycoplasma, chlamydia, intensive care unit
Abstract: Community-acquired pneumonia (CAP) is a relatively common and potentially serious infection that affects both immunocompetent and immunosuppressive adults throughout the world. The annual incidence of CAP in the United States is approximately 4 million cases. CAP due to atypical pathogens accounts for approximately 20 to 40 percent of cases necessitating hospitalization. There are few data regards to the prevalence rates of severe CAP due to atypical pathogens necessitating admission to the intensive care unit. This review article summarizes clinical features, diagnostic criteria, differential diagnosis, and management based on guidelines of medical societies.
Export Options
About this article
Cite this article as:
Michalopoulos Argyris, Rizos Michael and Falagas E. Matthew, Severe Community-Acquired Pneumonia (CAP) due to Atypical Pathogens, Current Respiratory Medicine Reviews 2005; 1 (3) . https://dx.doi.org/10.2174/157339805774598009
DOI https://dx.doi.org/10.2174/157339805774598009 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Juvenile Systemic Lupus Erythematosus
Current Pediatric Reviews Epidemiological Review of Gonococcal Infection
Current Women`s Health Reviews Marfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections
Current Pharmaceutical Design Maternal Sepsis: Current Approaches to Recognition and Clinical Management
Current Women`s Health Reviews <i>In Vitro</i> Evaluation of Immunogenicity of Recombinant OMP25 Protein Obtained from <i>Endemic Brucella</i> abortus Biovar 3 as Vaccine Candidate Molecule Against Animal Brucellosis
Protein & Peptide Letters Non-Microbicidal Control of Bacterial Biofilms with Small Molecules
Anti-Infective Agents Activation of Macrophages: Establishing a Role for Polysaccharides in Drug Delivery Strategies Envisaging Antibacterial Therapy
Current Pharmaceutical Design Short Term Statin Treatment Improves Survival and Differentially Regulates Macrophage-Mediated Responses to Staphylococcus aureus
Current Pharmaceutical Biotechnology β-Lactams in the New Millennium. Part-II: Cephems, Oxacephems, Penams and Sulbactam
Mini-Reviews in Medicinal Chemistry Pneumococcal Infections at Hajj: Current Knowledge Gaps
Infectious Disorders - Drug Targets Mucopolysaccharidosis Type IVA (Morquio A Disease): Clinical Review and Current Treatment: A Special Review
Current Pharmaceutical Biotechnology First Report on the Characteristics of Methicillin-Resistant <i>Staphylococcus Capitis</i> Isolates and an NRCS-A-clone Related Isolate Obtained from Iranian Children
Infectious Disorders - Drug Targets Anionic Antimicrobial Peptides from Eukaryotic Organisms
Current Protein & Peptide Science Disseminated TB in an Immunocompetent Patient: A Case Report
Infectious Disorders - Drug Targets The Impact of Methodology and Confounding Variables on the Association Between Major Depression and Coronary Heart Disease: Review and Recommendations
Current Psychiatry Reviews Novel Perspective for Antithrombotic Therapy in TAVI
Current Pharmaceutical Design Protective Effects of Astaxanthin on Nephrotoxicity in Rats with Induced Renovascular Occlusion
Combinatorial Chemistry & High Throughput Screening Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting
Current Pharmaceutical Design The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects
Current Cardiology Reviews The Importance of Guidelines in the Development and Application of Probiotics
Current Pharmaceutical Design